Income Statement Johnson & Johnson

Equities

JNJ

US4781601046

Pharmaceuticals

Market Closed - Nyse Other stock markets 20:00:02 16/03/2026 GMT			Pre-market 11:21:55
243.19 ^USD	+0.69%		243.11	-0.03%

09:32am	HSBC Adjusts Price Target on Johnson & Johnson to $280 From $265, Maintains Buy Rating	MT
03-16	Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer	CI

bec71602a0e410e28e2fadf78425b2.nW-8hUOHWJqbSl-VLcMFw3RCAnIbNX6OFV7ik0Xjvf4.2AXazBTmMtX-Jzn6f5dT8R1vVgdOUg7IXxil_RGmy5HPK4_AIsYW0PYrKA

Published financial data: JOHNSON & JOHNSON

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	93.78B	94.94B	85.16B	88.82B	94.19B
Total Revenues	93.78B	94.94B	85.16B	88.82B	94.19B
Cost of Goods Sold, Total	29.76B	30.99B	26.24B	27.04B	30.06B
Gross Profit	64.02B	63.95B	58.92B	61.78B	64.13B
Selling General & Admin Expenses, Total	24.06B	23.6B	20.17B	21.95B	23.13B
R&D Expenses	14.71B	14.6B	15.08B	17.23B	14.66B
Other Operating Expenses, Total	38.77B	38.21B	35.25B	39.18B	37.8B
Operating Income	25.25B	25.75B	23.66B	22.6B	26.33B
Interest Expense, Total	-183M	-276M	-772M	-755M	-971M
Interest And Investment Income	53M	490M	1.26B	1.33B	1.06B
Net Interest Expenses	-130M	214M	489M	577M	85M
Currency Exchange Gains (Loss)	-236M	-328M	-366M	-214M	-254M
Other Non Operating Income (Expenses)	991M	1.83B	1.66B	1.48B	851M
EBT, Excl. Unusual Items	25.87B	27.46B	25.45B	24.45B	27.02B
Restructuring Charges	-452M	-521M	-798M	-269M	-512M
Merger & Related Restructuring Charges	-117M	-300M	-200M	-1.2B	-300M
Gain (Loss) On Sale Of Investments	1.09B	-700M	-600M	-300M	400M
Gain (Loss) On Sale Of Assets	617M	380M	117M	226M	263M
Asset Writedown	-936M	-1.22B	-1.3B	-405M	-204M
In Process R&D Expenses	-900M	-783M	-313M	-211M	-81M
Legal Settlements	-2.3B	-900M	-6.9B	-5.5B	6B
Other Unusual Items	-100M	-1.7B	-400M	-100M	-
EBT, Incl. Unusual Items	22.78B	21.72B	15.06B	16.69B	32.58B
Income Tax Expense	1.9B	3.78B	1.74B	2.62B	5.78B
Earnings From Continuing Operations	20.88B	17.94B	13.33B	14.07B	26.8B
Earnings Of Discontinued Operations	-	-	21.83B	-	-
Net Income to Company	20.88B	17.94B	35.15B	14.07B	26.8B
Net Income - (IS)	20.88B	17.94B	35.15B	14.07B	26.8B
Net Income to Common Incl Extra Items	20.88B	17.94B	35.15B	14.07B	26.8B
Net Income to Common Excl. Extra Items	20.88B	17.94B	13.33B	14.07B	26.8B
Per Share Items
Net EPS - Basic	7.93	6.83	13.88	5.84	11.13
Basic EPS - Continuing Operations	7.93	6.83	5.26	5.84	11.13
Basic Weighted Average Shares Outstanding	2.63B	2.63B	2.53B	2.41B	2.41B
Net EPS - Diluted	7.81	6.73	13.72	5.79	11.03
Diluted EPS - Continuing Operations	7.81	6.73	5.2	5.79	11.03
Diluted Weighted Average Shares Outstanding	2.67B	2.66B	2.56B	2.43B	2.43B
Normalized Basic EPS	6.14	6.54	6.28	6.35	7.01
Normalized Diluted EPS	6.05	6.44	6.21	6.29	6.95
Dividend Per Share	4.19	4.45	4.7	4.91	5.14
Payout Ratio	52.84	65.11	33.48	84.05	46.19
American Depositary Receipts Ratio (ADR)	0.07	0.07	0.07	0.07	0.07
Supplemental Items
EBITDA	32.64B	32.72B	30.77B	29.94B	33.84B
EBITA	29.95B	30.05B	28.16B	27.1B	30.93B
EBIT	25.25B	25.75B	23.66B	22.6B	26.33B
EBITDAR	32.94B	33.02B	30.97B	30.14B	34.04B
Effective Tax Rate - (Ratio)	8.33	17.42	11.53	15.71	17.73
Current Domestic Taxes	1.52B	2.38B	2.7B	2.2B	1.16B
Current Foreign Taxes	2.45B	3.07B	3.09B	2.6B	3.08B
Total Current Taxes	3.98B	5.45B	5.8B	4.8B	4.24B
Deferred Domestic Taxes	583M	-2.08B	-3.44B	-2.54B	2.01B
Deferred Foreign Taxes	-2.66B	418M	-619M	356M	-470M
Total Deferred Taxes	-2.08B	-1.66B	-4.06B	-2.18B	1.54B
Normalized Net Income	16.17B	17.17B	15.91B	15.28B	16.88B
Interest Capitalized	49M	49M	70M	79M	114M
Non-Cash Pension Expense	-798M	-1.37B	-1.57B	-1.17B	-814M
Supplemental Operating Expense Items
Advertising Expense	2.7B	2.1B	500M	600M	1.6B
Selling and Marketing Expenses	2.7B	2.1B	500M	600M	1.6B
Research And Development Expense From Footnotes	15.61B	15.39B	15.4B	17.44B	14.75B
Net Rental Expense, Total	300M	300M	200M	200M	200M
Imputed Operating Lease Interest Expense	15.66M	20.6M	37.86M	39.09M	39.83M
Imputed Operating Lease Depreciation	284M	279M	162M	161M	160M
Stock-Based Comp., Other (Total)	1.14B	1.14B	1.16B	1.18B	1.35B
Total Stock-Based Compensation	1.14B	1.14B	1.16B	1.18B	1.35B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.49B	14.13B	21.86B	24.1B	19.71B
Short Term Investments	17.12B	9.39B	1.07B	417M	393M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	31.61B	23.52B	22.93B	24.52B	20.1B
Accounts Receivable, Total	15.28B	16.16B	14.87B	14.84B	17.18B
Total Receivables	15.28B	16.16B	14.87B	14.84B	17.18B
Inventory	10.39B	12.48B	11.18B	12.44B	14.19B
Prepaid Expenses	3.7B	3.13B	4.51B	4.08B	4.15B
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	60.98B	55.29B	53.5B	55.89B	55.62B
Gross Property Plant And Equipment	48.58B	50.35B	48.78B	49.87B	55.66B
Accumulated Depreciation	-28.72B	-29.45B	-27.88B	-28.25B	-31.2B
Net Property Plant And Equipment	19.86B	20.9B	20.9B	21.62B	24.47B
Long-term Investments	2.38B	1.27B	9.07B	5.52B	1.58B
Goodwill	35.25B	45.23B	36.56B	44.2B	48.77B
Other Intangibles, Total	46.39B	48.32B	34.18B	37.62B	50.4B
Deferred Tax Assets Long-Term	10.22B	9.12B	9.28B	10.46B	6.87B
Other Long-Term Assets, Total	6.93B	7.23B	4.08B	4.79B	11.49B
Total Assets	182B	187B	168B	180B	199B
Liabilities
Accounts Payable, Total	11.06B	11.7B	9.63B	10.31B	11.99B
Accrued Expenses, Total	29.29B	29.2B	30.21B	30.26B	32.25B
Short-term Borrowings	1.64B	11.22B	1.98B	4.23B	6.5B
Current Portion of Long-Term Debt	2.13B	1.55B	1.47B	1.75B	2B
Current Portion of Leases	-	-	-	-	-
Current Income Taxes Payable	1.11B	2.13B	2.99B	3.77B	1.39B
Total Current Liabilities	45.23B	55.8B	46.28B	50.32B	54.13B
Long-Term Debt	29.98B	26.89B	25.88B	30.65B	39.44B
Long-Term Leases	1B	1.3B	1.1B	1.2B	1.4B
Pension & Other Post Retirement Benefits	8.9B	6.77B	7.15B	7.26B	6.96B
Deferred Tax Liability Non Current	7.49B	6.37B	3.19B	2.45B	6.79B
Other Non Current Liabilities	15.4B	13.44B	15.18B	16.74B	8.95B
Total Liabilities	108B	111B	98.78B	109B	118B
Common Stock, Total	3.12B	3.12B	3.12B	3.12B	3.12B
Retained Earnings	123B	128B	154B	156B	169B
Treasury Stock	-39.1B	-41.69B	-75.66B	-75.68B	-75.62B
Comprehensive Income and Other	-13.06B	-12.97B	-12.53B	-11.74B	-14.93B
Total Common Equity	74.02B	76.8B	68.77B	71.49B	81.54B
Total Equity	74.02B	76.8B	68.77B	71.49B	81.54B
Total Liabilities And Equity	182B	187B	168B	180B	199B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.63B	2.6B	2.41B	2.41B	2.41B
ECS Total Common Shares Outstanding	2.63B	2.61B	2.41B	2.41B	2.41B
Book Value / Share	28.16	29.39	28.57	29.7	33.86
Tangible Book Value	-7.62B	-16.75B	-1.96B	-10.33B	-17.63B
Tangible Book Value Per Share	-2.9	-6.41	-0.81	-4.29	-7.32
Total Debt	34.75B	40.96B	30.43B	37.83B	49.33B
Net Debt	3.14B	17.44B	7.5B	13.31B	29.23B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-348M	-1.88B	-1.86B	-3.08B	-4.41B
Debt Equivalent Oper. Leases	2.4B	2.4B	1.6B	1.6B	1.6B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.59B	2.07B	2.36B	2.34B	2.53B
Inventories - Work In Process, Total	2.29B	1.7B	1.95B	2.82B	3.83B
Inventories - Finished Goods, Total	6.51B	8.71B	6.87B	7.29B	7.83B
Land - (BS)	884M	859M	795M	718M	701M
Buildings, Total	12.88B	12.99B	12.38B	12.32B	13.43B
Machinery, Total	29.77B	30.43B	28.98B	29.44B	32.87B
Full Time Employees	142K	153K	132K	138K	138K
Accumulated Allowance for Doubtful Accounts (Supple)	230M	203M	166M	167M	183M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	20.88B	17.94B	35.15B	14.07B	26.8B
Depreciation & Amortization - CF	2.69B	2.67B	2.6B	2.84B	2.9B
Amortization of Goodwill and Intangible Assets - (CF)	4.7B	4.3B	4.5B	4.5B	4.6B
Depreciation & Amortization, Total	7.39B	6.97B	7.1B	7.34B	7.5B
(Gain) Loss From Sale Of Asset	-617M	-380M	-117M	-226M	-263M
Asset Writedown & Restructuring Costs	989M	1.22B	1.78B	2.25B	313M
Provision for Credit Losses	-48M	-	-	-	-
Stock-Based Compensation (CF)	1.14B	1.14B	1.16B	1.18B	1.35B
Provision and Write-off of Bad Debts	-	-17M	-	11M	-1M
Net Cash From Discontinued Operations	-	-	-20.6B	-	-
Other Operating Activities, Total	-2.08B	-1.66B	-4.19B	-2.18B	1.54B
Change In Accounts Receivable	-2.4B	-1.29B	-624M	-406M	-1.78B
Change In Inventories	-1.25B	-2.53B	-1.32B	-1.13B	-1.45B
Change In Accounts Payable	2.44B	1.1B	2.35B	1.62B	2.38B
Change in Other Net Operating Assets	-3.02B	-1.29B	2.11B	1.75B	-11.86B
Cash from Operations	23.41B	21.19B	22.79B	24.27B	24.53B
Capital Expenditure	-3.65B	-4.01B	-5.01B	-4.42B	-4.83B
Sale of Property, Plant, and Equipment	711M	543M	358M	675M	720M
Cash Acquisitions	-60M	-17.65B	-	-15.15B	-17.54B
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-1.78B	-385M
Investment in Marketable and Equity Securities, Total	-5.39B	9.22B	8.48B	736M	741M
Other Investing Activities, Total	-294M	-478M	-2.95B	1.34B	-2.29B
Cash from Investing	-8.68B	-12.37B	878M	-18.6B	-23.59B
Short Term Debt Issued, Total	2B	16.13B	13.74B	15.28B	14.59B
Long-Term Debt Issued, Total	5M	2M	-	6.66B	9.14B
Total Debt Issued	2B	16.14B	13.74B	21.94B	23.72B
Short Term Debt Repaid, Total	-1.19B	-6.55B	-22.97B	-9.46B	-12.33B
Long-Term Debt Repaid, Total	-1.8B	-2.13B	-1.55B	-1.45B	-1.76B
Total Debt Repaid	-2.99B	-8.68B	-24.52B	-10.92B	-14.09B
Issuance of Common Stock	1.04B	1.33B	1.09B	838M	3.42B
Repurchase of Common Stock	-3.46B	-6.04B	-5.05B	-2.43B	-5.95B
Common Dividends Paid	-11.03B	-11.68B	-11.77B	-11.82B	-12.38B
Common & Preferred Stock Dividends Paid	-11.03B	-11.68B	-11.77B	-11.82B	-12.38B
Other Financing Activities, Total	395M	65M	10.69B	-736M	-260M
Cash from Financing	-14.05B	-8.87B	-15.82B	-3.13B	-5.54B
Foreign Exchange Rate Adjustments	-178M	-312M	-112M	-289M	201M
Net Change in Cash	502M	-360M	7.73B	2.25B	-4.4B
Supplemental Items
Cash Interest Paid	941M	933M	1.77B	1.91B	1.86B
Cash Income Tax Paid (Refund)	4.77B	5.22B	8.57B	6.71B	6.54B
Levered Free Cash Flow	18.82B	19.19B	19.79B	16.67B	16.63B
Unlevered Free Cash Flow	18.93B	19.36B	20.27B	17.14B	17.24B
Change In Net Working Capital	1.72B	833M	-2.23B	-704M	2.86B
Net Debt Issued / Repaid	-990M	7.45B	-10.78B	11.02B	9.64B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.84	8.71	8.33	8.13	8.68
Return on Total Capital	15.14	14.21	13.65	13.55	13.7
Return On Equity %	30.41	23.79	18.31	20.06	35.03
Return on Common Equity	30.41	23.79	18.31	20.06	35.03
Margin Analysis
Gross Profit Margin %	68.27	67.36	69.18	69.56	68.08
SG&A Margin	25.66	24.86	23.68	24.71	24.56
EBITDA Margin %	34.8	34.46	36.13	33.71	35.92
EBITA Margin %	31.93	31.65	33.07	30.51	32.84
EBIT Margin %	26.92	27.12	27.79	25.45	27.96
Income From Continuing Operations Margin %	22.26	18.9	15.65	15.84	28.46
Net Income Margin %	22.26	18.9	41.28	15.84	28.46
Net Avail. For Common Margin %	22.26	18.9	15.65	15.84	28.46
Normalized Net Income Margin	17.24	18.08	18.68	17.2	17.93
Levered Free Cash Flow Margin	20.07	20.21	23.24	18.76	17.66
Unlevered Free Cash Flow Margin	20.19	20.39	23.8	19.29	18.3
Asset Turnover
Asset Turnover	0.53	0.51	0.48	0.51	0.5
Fixed Assets Turnover	4.73	4.66	4.27	4.18	4.09
Receivables Turnover (Average Receivables)	6.5	6.04	5.89	5.98	5.88
Inventory Turnover (Average Inventory)	3.02	2.71	2.45	2.29	2.26
Short Term Liquidity
Current Ratio	1.35	0.99	1.16	1.11	1.03
Quick Ratio	1.04	0.71	0.82	0.78	0.69
Operating Cash Flow to Current Liabilities	0.52	0.38	0.49	0.48	0.45
Days Sales Outstanding (Average Receivables)	56.01	60.27	61.79	60.89	61.87
Days Outstanding Inventory (Average Inventory)	120.69	134.32	148.75	159.04	161.24
Average Days Payable Outstanding	121.5	125.19	130.83	128.26	127.59
Cash Conversion Cycle (Average Days)	55.2	69.4	79.71	91.67	95.51
Long Term Solvency
Total Debt/Equity	46.95	53.33	44.25	52.92	60.5
Total Debt / Total Capital	31.95	34.78	30.68	34.61	37.69
LT Debt/Equity	41.86	36.7	39.23	44.55	50.08
Long-Term Debt / Total Capital	28.49	23.94	27.2	29.13	31.2
Total Liabilities / Total Assets	59.33	59.01	58.96	60.31	59.07
EBIT / Interest Expense	137.96	93.29	30.65	29.94	27.12
EBITDA / Interest Expense	179.98	119.63	40.11	39.92	35.05
(EBITDA - Capex) / Interest Expense	160.03	105.1	33.62	34.06	30.08
Total Debt / EBITDA	1.06	1.24	0.98	1.26	1.45
Net Debt / EBITDA	0.1	0.53	0.24	0.44	0.86
Total Debt / (EBITDA - Capex)	1.19	1.41	1.17	1.47	1.69
Net Debt / (EBITDA - Capex)	0.11	0.6	0.29	0.52	1
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.55	1.25	6.46	4.3	6.05
Gross Profit, 1 Yr. Growth %	18.21	0.05	6.36	4.52	3.79
EBITDA, 1 Yr. Growth %	18.49	0.54	7.92	-3.32	13.01
EBITA, 1 Yr. Growth %	19.72	0.66	7.99	-4.45	14.14
EBIT, 1 Yr. Growth %	24.28	2.37	6.69	-5.29	16.51
Earnings From Cont. Operations, 1 Yr. Growth %	41.89	-14.07	-18.6	5.55	90.56
Net Income, 1 Yr. Growth %	41.89	-14.07	95.94	-59.99	90.56
Normalized Net Income, 1 Yr. Growth %	27.84	3.97	6.7	-5.07	10.96
Diluted EPS Before Extra, 1 Yr. Growth %	41.74	-13.83	-15.31	11.35	90.5
Accounts Receivable, 1 Yr. Growth %	12.57	5.74	5.94	-0.21	15.74
Inventory, 1 Yr. Growth %	11.16	20.18	8.89	11.3	14.04
Net Property, Plant and Equip., 1 Yr. Growth %	0.49	5.24	10.09	3.45	13.19
Total Assets, 1 Yr. Growth %	4.07	2.94	-10.58	7.49	10.61
Tangible Book Value, 1 Yr. Growth %	-71.28	119.99	-186.38	427.21	70.71
Common Equity, 1 Yr. Growth %	16.98	3.76	-10.46	3.95	14.06
Cash From Operations, 1 Yr. Growth %	-0.54	-9.47	7.54	6.47	1.09
Capital Expenditures, 1 Yr. Growth %	9.11	9.78	25.04	0.98	9.22
Levered Free Cash Flow, 1 Yr. Growth %	-13.69	2.28	31.12	-16.99	-0.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-13.67	2.58	32.8	-16.64	0.6
Dividend Per Share, 1 Yr. Growth %	5.28	6.21	5.62	4.47	4.68
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.9	7.22	4	5.38	5.17
Gross Profit, 2 Yr. CAGR %	8.38	8.67	3.18	5.61	4.33
EBITDA, 2 Yr. CAGR %	7.44	9.08	4.44	2.48	4.87
EBITA, 2 Yr. CAGR %	7.81	9.7	4.57	1.94	4.8
EBIT, 2 Yr. CAGR %	8.97	12.71	4.78	0.94	5.49
Earnings From Cont. Operations, 2 Yr. CAGR %	17.51	10.42	-13.48	-7.3	41.82
Net Income, 2 Yr. CAGR %	17.51	10.42	29.76	-11.46	-12.68
Normalized Net Income, 2 Yr. CAGR %	22.91	26.93	10.99	6.5	114.88
Diluted EPS Before Extra, 2 Yr. CAGR %	17.78	10.52	-11.64	-2.89	45.64
Accounts Receivable, 2 Yr. CAGR %	2.73	9.1	-1.35	2.82	7.47
Inventory, 2 Yr. CAGR %	7.31	15.58	3.75	10.09	12.66
Net Property, Plant and Equip., 2 Yr. CAGR %	3.18	2.84	2.57	6.72	8.21
Total Assets, 2 Yr. CAGR %	7.42	3.51	-4.05	-1.96	9.04
Tangible Book Value, 2 Yr. CAGR %	-40.91	-20.52	-49.28	113.4	200
Common Equity, 2 Yr. CAGR %	11.57	10.17	-3.61	-3.52	8.89
Cash From Operations, 2 Yr. CAGR %	-0.01	-5.11	-1.33	7	3.74
Capital Expenditures, 2 Yr. CAGR %	2.18	9.44	17.16	9.26	5.02
Levered Free Cash Flow, 2 Yr. CAGR %	-12.9	-6.13	12.02	4.04	-8.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	-12.98	-5.98	12.97	4.92	-8.15
Dividend Per Share, 2 Yr. CAGR %	5.7	5.74	5.91	5.04	4.58
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.75	4.98	1.03	4.1	5.6
Gross Profit, 3 Yr. CAGR %	5.52	5.47	2.85	3.74	5
EBITDA, 3 Yr. CAGR %	5.11	4.99	3.82	2.01	5.88
EBITA, 3 Yr. CAGR %	5.4	5.26	4.1	1.71	5.85
EBIT, 3 Yr. CAGR %	6.04	6.59	5.3	1.59	5.89
Earnings From Cont. Operations, 3 Yr. CAGR %	10.92	5.87	-3.25	-7.55	17.86
Net Income, 3 Yr. CAGR %	10.92	5.87	33.68	-12.33	14.32
Normalized Net Income, 3 Yr. CAGR %	10.04	17.05	14.3	5.77	7.82
Diluted EPS Before Extra, 3 Yr. CAGR %	11.66	6.13	-1.91	-4.56	21.56
Accounts Receivable, 3 Yr. CAGR %	2.73	3.72	3.09	-0.97	6.96
Inventory, 3 Yr. CAGR %	6.5	11.44	6.17	6.21	11.39
Net Property, Plant and Equip., 3 Yr. CAGR %	5.25	3.86	1.87	2.86	8.83
Total Assets, 3 Yr. CAGR %	5.97	5.91	-1.42	-0.35	2.06
Tangible Book Value, 3 Yr. CAGR %	-25.36	-8.42	-58.04	10.69	98.1
Common Equity, 3 Yr. CAGR %	7.4	8.9	2.82	-1.15	2.02
Cash From Operations, 3 Yr. CAGR %	1.78	-3.27	-1.07	1.2	4.99
Capital Expenditures, 3 Yr. CAGR %	-0.16	4.65	14.41	6.6	9.25
Levered Free Cash Flow, 3 Yr. CAGR %	2.95	-8.2	-3.13	1.86	2.61
Unlevered Free Cash Flow, 3 Yr. CAGR %	1.93	-8.17	-2.54	2.56	3.46
Dividend Per Share, 3 Yr. CAGR %	5.78	5.87	5.7	5.43	4.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.46	4.43	0.86	1.6	2.67
Gross Profit, 5 Yr. CAGR %	5.03	4.63	1.57	2.54	3.44
EBITDA, 5 Yr. CAGR %	5.54	5.92	1.83	1.15	4.24
EBITA, 5 Yr. CAGR %	6.01	6.53	1.95	1.02	4.38
EBIT, 5 Yr. CAGR %	3.59	6.38	2.25	1.23	5.38
Earnings From Cont. Operations, 5 Yr. CAGR %	4.77	69.04	-2.72	-1.43	12.74
Net Income, 5 Yr. CAGR %	4.77	69.04	18.11	-1.43	12.74
Normalized Net Income, 5 Yr. CAGR %	5.24	8.97	5.56	7.38	9.65
Diluted EPS Before Extra, 5 Yr. CAGR %	5.66	70.29	-1.51	0.56	14.89
Accounts Receivable, 5 Yr. CAGR %	5.49	3.68	1.08	0.49	4.82
Inventory, 5 Yr. CAGR %	4.99	7.33	5.39	6.65	8.72
Net Property, Plant and Equip., 5 Yr. CAGR %	4.53	4.21	4.17	2.99	4.36
Total Assets, 5 Yr. CAGR %	5.21	3.56	1.84	2.69	2.64
Tangible Book Value, 5 Yr. CAGR %	-18.16	-7.68	-36.05	-13.89	-7.84
Common Equity, 5 Yr. CAGR %	1	5.01	2.85	3.75	5.2
Cash From Operations, 5 Yr. CAGR %	4.52	0.13	0.53	0.72	0.83
Capital Expenditures, 5 Yr. CAGR %	2.51	4.1	6.44	4.81	7.62
Levered Free Cash Flow, 5 Yr. CAGR %	6.48	1.39	2.79	-7.64	-5.24
Unlevered Free Cash Flow, 5 Yr. CAGR %	5.92	0.92	2.55	-7.27	-4.67
Dividend Per Share, 5 Yr. CAGR %	5.87	6.03	5.83	5.54	5.25